Patents by Inventor Clare Selden

Clare Selden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160316742
    Abstract: The present invention relates to the field of extracorporeal liver perfusion and, more particularly, to the design of a chamber in which a biological component can be housed to form e.g. a bio-artificial liver (BAL). It also relates to a bio-artificial liver per se, it's components and methodological steps associated with its development and use. The chamber (10) for the biological component (100) of a bio-artificial liver (200) is configured to allow: •Proliferation of the biological component, in situ; •Cryopreservation of the biological component, in situ, and •Perfusion of the biological component, in situ.
    Type: Application
    Filed: July 13, 2016
    Publication date: November 3, 2016
    Inventors: Clare Selden, Humphrey Hodgson, Sam Coward
  • Patent number: 9402944
    Abstract: The present invention relates to the field of extracorporeal liver perfusion and, more particularly, to the design of a chamber in which a biological component can be housed to form e.g. a bio-artificial liver (BAL). It also relates to a bio-artificial liver per se, it's components and methodological steps associated with its development and use. The chamber (10) for the biological component (100) of a bio-artificial liver (200) is configured to allow: • Proliferation of the biological component, in situ; • Cryopreservation of the biological component, in situ, and • Perfusion of the biological component, in situ.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: August 2, 2016
    Assignee: University College London
    Inventors: Clare Selden, Humphrey Hodgson, Sam Coward
  • Publication number: 20110313540
    Abstract: The present invention relates to a method of growing a plurality of cells (110) to performance competence in a matrix forming agent (120) containing one or more density modifiers (130), characterized in that the cells are grown in a culture media supplemented with from 2-20% human plasma. It also relates to a biological component (100) comprising: i. a matrix forming agent (120), ii. a plurality of cells (110), and iii. one or more density modifiers (130), wherein at performance competence, the cells are present in the matrix forming agent at a density of at least 3×107 cells/ml.
    Type: Application
    Filed: December 16, 2009
    Publication date: December 22, 2011
    Inventors: Clare Selden, Eloy Erro
  • Publication number: 20110125286
    Abstract: The present invention relates to the field of extracorporeal liver perfusion and, more particularly, to the design of a chamber in which a biological component can be housed to form e.g. a bio-artificial liver (BAL). It also relates to a bio-artificial liver per se, it's components and methodological steps associated with its development and use. The chamber (10) for the biological component (100) of a bio-artificial liver (200) is configured to allow: • Proliferation of the biological component, in situ; • Cryopreservation of the biological component, in situ, and • Perfusion of the biological component, in situ.
    Type: Application
    Filed: June 25, 2008
    Publication date: May 26, 2011
    Inventors: Clare Selden, Humphrey Hodgson, Sam Coward